Trials / Conditions / Hypoactive Sexual Desire Disorder (HSDD)
Hypoactive Sexual Desire Disorder (HSDD)
6 registered clinical trials studyying Hypoactive Sexual Desire Disorder (HSDD).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study NCT03619005 | EndoCeutics Inc. | Phase 3 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers NCT03102489 | Ivix LLX | Phase 1 |
| Completed | Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire NCT03080298 | Ivix LLX | Phase 2 |
| Completed | Acupuncture for Sexual Dysfunction NCT02070029 | TriHealth Inc. | N/A |
| Completed | Stress Hormones, Mood and Women's Sexual Desire (MODEST) NCT01702818 | University of British Columbia | — |
| Completed | Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low NCT00349791 | Warner Chilcott | Phase 3 |